Vaxcyte (PCVX) SVP Elvia Cowan Sells Shares for Tax Withholding

What Happened

• Elvia Cowan, SVP, Finance & CAO of Vaxcyte, surrendered a total of 569 shares to the company to cover tax withholding obligations arising from RSU vesting. The dispositions were reported as tax-withholding transactions (code F) rather than open-market sales.
• Details: 243 shares surrendered on 2026-08-31 at $60.74 each ($14,760) and 326 shares surrendered on 2026-09-02 at $61.58 each ($20,075). Combined value of the shares surrendered is approximately $34,835.

Key Details

• Transaction dates and prices:
  • 2026-08-31: 243 shares @ $60.74 = $14,760 (surrender for tax withholding)
  • 2026-09-02: 326 shares @ $61.58 = $20,075 (surrender for tax withholding)
• Total shares surrendered: 569; total value ≈ $34,835.
• Shares owned after transaction: Not specified in the provided excerpt. Footnote in the filing notes that the insider’s reported holdings include 781 shares acquired under the company’s Employee Stock Purchase Plan on May 15, 2026.
• Footnotes: F1 indicates shares were surrendered to cover applicable tax withholding on RSU vesting. F2 notes inclusion of 781 ESPP shares (May 15, 2026).
• Filing: Report filed 2026-09-02 for a period ending 2026-08-31; no late-filing flag is indicated in the provided details.

Context

• These were tax-withholding dispositions (company-retained shares to satisfy tax), a routine administrative step when restricted stock units vest — not an open-market sale signaling investment intent.
• For retail investors: such F-code transactions are common following RSU vesting and should not be interpreted as a directional bet by the insider.